Salisbury Foundation Trust

FOI_5989

Internal Reference Number: FOI_5989

Date Request Received: 12/01/2021 10:47:50

Date Request Replied To: 13/01/2021 14:25:22

This response was sent via: By Email

Request Summary: biologic products for the treatment of severe asthma

Request Category: Researcher

 
Question Number 1:
How many patients have been treated (for any disease) in the last three months with:
• Benralizumab
• Omalizumab
• Reslizumab
• Mepolizumab
 
Answer To Question 1:
Please see attached refusal notice explaining why the Trust is unable to answer this FOI.
 
Question Number 2:
How many patients have been treated in the last three months, for asthma ONLY, with:
• Dupilumab
• Upadacitinib
 
Answer To Question 2:
Please see answer to question 1.
 
Question Number 3:
How many patients have been treated (with any medication) for severe asthma in the last three months? Of these patients, how many were children?
 
Answer To Question 3:
Please see answer to question 1.
 
To return to the list of all the FOI requests please click here

Our staff at Salisbury District Hospital have long been well regarded for the quality of care and treatment they provide for our patients and for their innovation, commitment and professionalism. This has been recognised in a wide range of achievements and it is reflected in our award of NHS Foundation Trust status. This is afforded to hospitals that provide the highest standards of care.

Salisbury NHS Foundation Trust, Salisbury District Hospital, Salisbury, Wiltshire, SP2 8BJ
T: 01722 336262 E: sft.pals@nhs.net
© 2021 Salisbury NHS Foundation Trust
Trust Values